Xeris Biopharma Holdings, Inc.
XERS
$4.16
$0.215.32%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 3.20% | -10.53% | -11.20% | 20.57% | 9.82% |
| Total Receivables | -1.76% | -3.07% | 13.43% | -4.55% | -14.73% |
| Inventory | 6.77% | 4.98% | 5.13% | 5.25% | 1.82% |
| Prepaid Expenses | 4.36% | -2.92% | -3.68% | 32.16% | -27.48% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 2.99% | -4.43% | -1.70% | 10.89% | -1.13% |
|
|
|||||
| Total Current Assets | 2.99% | -4.43% | -1.70% | 10.89% | -1.13% |
| Net Property, Plant & Equipment | -0.56% | -1.14% | -0.39% | -1.25% | -1.41% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -2.67% | -2.60% | -2.53% | -2.47% | -2.41% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -0.66% | -0.93% | 19.07% | 1.63% | -5.55% |
| Total Assets | 0.61% | -3.20% | -1.45% | 4.34% | -1.58% |
|
|
|||||
| Total Accounts Payable | -69.27% | 28.51% | -18.27% | -38.66% | -4.25% |
| Total Accrued Expenses | 28.91% | -5.79% | 4.04% | -1.55% | 16.03% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 0.39% | 297.57% | 14.77% | 32.30% | 47.72% |
| Total Finance Division Other Current Liabilities | 9.62% | 4.47% | 7.30% | -52.38% | 3.70% |
| Total Other Current Liabilities | 9.62% | 4.47% | 7.30% | -52.38% | 3.70% |
| Total Current Liabilities | 10.36% | 20.57% | 3.29% | -23.23% | 9.37% |
|
|
|||||
| Total Current Liabilities | 10.36% | 20.57% | 3.29% | -23.23% | 9.37% |
| Long-Term Debt | 0.36% | -6.18% | 0.35% | 20.29% | 0.27% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -1.13% | -1.11% | -1.11% | -1.06% | -1.11% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -76.99% | -22.53% | 27.72% | 1.70% | -24.84% |
| Total Liabilities | 0.93% | -0.45% | 1.51% | 4.98% | 1.69% |
|
|
|||||
| Common Stock & APIC | 0.60% | 1.06% | 0.78% | 2.72% | 0.45% |
| Retained Earnings | -0.77% | -2.42% | -2.36% | -3.08% | -2.22% |
| Treasury Stock & Other | -56.25% | 48.39% | 13.89% | -44.00% | 50.00% |
| Total Common Equity | -4.56% | -46.86% | -110.13% | -35.33% | -275.47% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -4.56% | -46.86% | -110.13% | -35.33% | -275.47% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -4.56% | -46.86% | -110.13% | -35.33% | -275.47% |
|
|
|||||
